Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

What is the purpose of this trial?

This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.


Participation Guidelines

Ages: 18 - 70 years

Gender: Both


National Institutes of Health

Dates: 02/27/2017 - 09/30/2023

Last Updated: 03/14/2017

Study HIC#: 1506016065

Get Involved

For more information about this study, contact:
Janet Lydecker
+1 203-737-4299
janet.lydecker@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Carlos M Grilo

Principal Investigator

Sub-Investigators